165 related articles for article (PubMed ID: 37452613)
1. Preparation and in vitro characterization studies of astaxanthin-loaded nanostructured lipid carriers with antioxidant properties.
Gu L; Wang W; Wu B; Ji S; Xia Q
J Biomater Appl; 2023 Aug; 38(2):292-301. PubMed ID: 37452613
[TBL] [Abstract][Full Text] [Related]
2. Nanostructured-lipid carriers-Chitosan hydrogel beads carrier system for loading of resveratrol: A new method of topical application.
Wu B; Li Y; Li YY; Shi ZH; Bian XH; Xia Q
J Biomater Appl; 2022 Mar; 36(8):1444-1457. PubMed ID: 34995470
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
Okonogi S; Riangjanapatee P
Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carriers for the encapsulation of phloretin: preparation and in vitro characterization studies.
Gu L; Sun R; Wang W; Xia Q
Chem Phys Lipids; 2022 Jan; 242():105150. PubMed ID: 34673008
[TBL] [Abstract][Full Text] [Related]
5. Development and Evaluation of Astaxanthin as Nanostructure Lipid Carriers in Topical Delivery.
Geng Q; Zhao Y; Wang L; Xu L; Chen X; Han J
AAPS PharmSciTech; 2020 Nov; 21(8):318. PubMed ID: 33175290
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes.
Na YG; Huh HW; Kim MK; Byeon JJ; Han MG; Lee HK; Cho CW
Acta Biomater; 2020 Jan; 101():507-518. PubMed ID: 31629894
[TBL] [Abstract][Full Text] [Related]
8. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers.
Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G
Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416
[TBL] [Abstract][Full Text] [Related]
10. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
Baek JS; Pham CV; Myung CS; Cho CW
Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
[TBL] [Abstract][Full Text] [Related]
11. Preparation of astaxanthin/zeaxanthin-loaded nanostructured lipid carriers for enhanced bioavailability: Characterization-, stability-and permeability study.
Radić K; Barbosa AI; Reis S; Marijan M; Lima SAC; Čepo DV
Acta Pharm; 2023 Dec; 73(4):581-599. PubMed ID: 38147480
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus-loaded lecithin-based nanostructured lipid carrier and nanoemulsion with propylene glycol monocaprylate as a liquid lipid: Formulation characterization and assessment of dermal delivery compared to referent ointment.
Savić V; Ilić T; Nikolić I; Marković B; Čalija B; Cekić N; Savić S
Int J Pharm; 2019 Oct; 569():118624. PubMed ID: 31419461
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of isopsoralen loaded nanostructured carrier and its in vitro transdermal permeation characteristics].
Pang JY; Liu X; Shen BD; Shen CY; Lian WQ; Liu J; Hu CX; Zhong RN; Xu RC; Yuan HL
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2473-2478. PubMed ID: 28840686
[TBL] [Abstract][Full Text] [Related]
14. Astaxanthin-Loaded Nanostructured Lipid Carriers for Preservation of Antioxidant Activity.
Rodriguez-Ruiz V; Salatti-Dorado JÁ; Barzegari A; Nicolas-Boluda A; Houaoui A; Caballo C; Caballero-Casero N; Sicilia D; Bastias Venegas J; Pauthe E; Omidi Y; Letourneur D; Rubio S; Gueguen V; Pavon-Djavid G
Molecules; 2018 Oct; 23(10):. PubMed ID: 30314284
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of 4-dedimethylamino sancycline (CMT-3) loaded nanostructured lipid carrier (CMT-3/NLC) formulations.
Yang X; Zhao L; Almasy L; Garamus VM; Zou A; Willumeit R; Fan S
Int J Pharm; 2013 Jun; 450(1-2):225-34. PubMed ID: 23608200
[TBL] [Abstract][Full Text] [Related]
16. Design and characterization of Nanostructured lipid carriers (NLC) and Nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil.
Krambeck K; Silva V; Silva R; Fernandes C; Cagide F; Borges F; Santos D; Otero-Espinar F; Lobo JMS; Amaral MH
Int J Pharm; 2021 May; 600():120444. PubMed ID: 33713760
[TBL] [Abstract][Full Text] [Related]
17. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
Nagaich U; Gulati N
Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
[TBL] [Abstract][Full Text] [Related]
18. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
19. Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer's Disease in Rat Model.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():4193-4227. PubMed ID: 37534058
[TBL] [Abstract][Full Text] [Related]
20. Possibility of nanostructured lipid carriers encapsulating astaxanthin from
Vu NB; Pham ND; Tran TN; Pham XH; Ngo DN; Nguyen MH
Int J Radiat Biol; 2024; 100(2):209-219. PubMed ID: 37819928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
